Clinical impact of TP53 alterations in adrenocortical carcinomas. - Wikidata - awgldk - TriplyDB

Clinical impact of TP53 alterations in adrenocortical carcinomas.

Clinical impact of TP53 alterations in adrenocortical carcinomas.

http://www.wikidata.org/entity/Q44510640

about

Diagnostic and prognostic features in adrenocortical carcinoma: a single institution case series and review of the literature Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma.Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies.Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers Development of adrenal cortex zonation.Targeting polo-like kinase 1, a regulator of p53, in the treatment of adrenocortical carcinoma.Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1.Genetics and epigenetics of adrenocortical tumors.Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.Diagnosis, treatment and outcome of adrenocortical cancer.The role of microRNAs in the adrenocortical carcinomas.Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.SDHB/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a Multinational Study of the European Network for the Study of Adrenal Tumors (ENS@T).Activating mutations of GNAS in canine cortisol-secreting adrenocortical tumors.

P2860

Q27021404-29E8FBA7-6040-464E-8E6C-B4E4EA1AA17C Q33570215-DAC93464-0E7B-4ED4-9130-E82782B82559 Q34431264-EBEB6E98-17CE-414B-91BB-A0D588C552E1 Q35151124-071E3452-E8D4-44D9-B46B-B38FD083C6A2 Q35800278-3F56DDBC-1BB1-46BE-BAE1-408E85A0F871 Q36452688-7B790E37-7C24-4AE9-92F1-A7DF4286BFDE Q37569272-780BC52D-4CDC-497B-A652-E631293F1123 Q38162079-61726F58-11A7-4350-9C5E-F47472B2D2C6 Q38202612-58CA76EB-27B6-43F4-951F-E8373B5F2D89 Q38358503-75267A9F-1AE6-41E3-824C-B22F56198CB7 Q38670433-C7315E42-F8DD-4D9E-B8B7-A9B9FC4B22E5 Q43993555-DD12F500-387D-4EE1-8A95-CFCD9658A8FB Q48221255-9A53D1A6-8AD6-468D-8D13-3ECA280479ED Q54240213-6448B6AB-BFE3-478E-BABA-6E983290BF81

P2860

Clinical impact of TP53 alterations in adrenocortical carcinomas.

http://www.wikidata.org/entity/Q44510640

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@en

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@nl

type

label

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@en

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@nl

prefLabel

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@en

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@nl

P1433

Q44510640-6FF1013D-9564-4CA6-BB76-4664C0C9266A

P1476

Q44510640-CD3EE20B-87C6-464E-95E8-E8849D2C1A01

P2093

Q44510640-01781D89-801C-4788-B1F8-550EE1693477

Q44510640-0C070F5A-CB55-4D19-AF24-4E7545BBC063

Q44510640-0CA726B9-FCE3-4C89-8BE1-16643D617E0E

Q44510640-64D90F2F-BF37-48EB-BA14-7BC26C098516

Q44510640-75BE6180-87C6-4FE0-A45B-BC82F44F7AC8

Q44510640-A6C1EA28-07BD-42D5-B001-CE68A8C45F9C

Q44510640-C34C8DE3-EBE6-4BA9-BDBD-5D6B894F2A90

Q44510640-C9BD73AD-AB81-4CC8-84EF-1163F4D20079

Q44510640-E167F688-9749-45A5-9F2D-1FAE061811B4

Q44510640-FDC73745-7DE5-407B-8143-83DFA870CB02

P2860

Q44510640-026D1AF6-35B5-40DD-90E2-062EA0ED9FCA

Q44510640-0ACE4AF6-46BA-4F71-9ED4-938411643658

Q44510640-2C9C54C2-9116-49AE-A413-99A69F246281

Q44510640-50C8134D-5567-437F-A5C3-361FF05280C6

Q44510640-53F5C49F-B5A1-4498-96F8-086AD4A8F24B

Q44510640-54E16447-2C46-40B8-8C0F-0840CE63A2EB

Q44510640-603D77F5-F4C0-4C7A-941D-9EBCBAEEAC4D

Q44510640-641FD340-9E68-4CEA-A528-9FEBE7BF0BC0

Q44510640-6C4A99C3-7114-4DB0-ACEA-8E6CF5D0B895

Q44510640-6E58DDF9-969D-4735-8E21-FC9CE92C6C2D

P2888

Q44510640-E2F84D13-47F3-4742-8086-74A445D3823B

P304

Q44510640-3D9DFE89-7DDE-4867-BF07-28D2BB567977

P31

Q44510640-2C31DBD7-1BE0-4106-9377-E1D288F95413

P356

Q44510640-3E16EDD1-4492-4A0B-A4D0-9CB55CCD6F93

P407

Q44510640-49206049-73C4-43FB-A3B0-4AC7F0D40CC3

P433

Q44510640-2813FAD6-7320-40FE-BDFF-8BEBCE6862C7

P478

Q44510640-C33B06CE-D062-4A30-9799-CD3BA6779782

P577

Q44510640-FC1F510E-4895-407A-936C-543BD26A75D0

P5875

Q44510640-24194767-53C7-4832-BD0D-7089309A62C0

P698

Q44510640-64ECAC3B-1498-4EEA-80C5-64C055AE0FAA

P356

S00423-011-0868-6

P1433

Langenbeck's Archives of Surgery

P1476

Clinical impact of TP53 alterations in adrenocortical carcinomas.

@en

P2093

Annette Ramaswamy

http://www.w3.org/2001/XMLSchema#string

Brunhilde Chaloupka

http://www.w3.org/2001/XMLSchema#string

Detlef K Bartsch

http://www.w3.org/2001/XMLSchema#string

Emily P Slater

http://www.w3.org/2001/XMLSchema#string

Jens Waldmann

http://www.w3.org/2001/XMLSchema#string

Martin Fassnacht

http://www.w3.org/2001/XMLSchema#string

Nikolaos Patsalis

http://www.w3.org/2001/XMLSchema#string

Peter Langer

http://www.w3.org/2001/XMLSchema#string

Volker Fendrich

http://www.w3.org/2001/XMLSchema#string

Wolfgang Saeger

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation and methylation analysis of TP53 in adrenal carcinogenesis.

An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.

Expression of the zinc-finger transcription factor Snail in adrenocortical carcinoma is associated with decreased survival.

Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Adrenocortical carcinoma. Clinical outcome at the end of the 20th century.

Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.

Multiple primary cancers in families with Li-Fraumeni syndrome.

P2888

s00423-011-0868-6

P304

209-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00423-011-0868-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

397

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51926335

http://www.w3.org/2001/XMLSchema#string

P698

22203015

http://www.w3.org/2001/XMLSchema#string